Skip to content

Clinical trials

Completed Observational Lung Diseases, Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Phase: Observational Status: Completed Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20056
20071
20102
20112
20121
20142
20151
20162
20181
20193
20204
20211
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)18
University of Michigan5
AstraZeneca2
Catholic University of the Sacred Heart2
RWTH Aachen University2
Royal Brompton & Harefield NHS Foundation Trust2
Universitätsklinikum Hamburg-Eppendorf2
Ambu A/S1
Columbia University1
Hacettepe University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive50
Pulmonary Disease, Chronic Obstructive32
Asthma13
Lung Diseases9
Cardiovascular Diseases5
Emphysema5
Hypertension4
Bronchitis3
Bronchitis, Chronic3
Respiratory Tract Diseases3

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.